In last trading session, Ernexa Therapeutics Inc (NASDAQ:ERNA) saw 0.41 million shares changing hands with its beta currently measuring 5.63. Company’s recent per share price level of $0.19 trading at $0.01 or 4.48% at ring of the bell on the day assigns it a market valuation of $9.88M. That closing price of ERNA’s stock is at a discount of -1278.95% from its 52-week high price of $2.62 and is indicating a premium of 15.79% from its 52-week low price of $0.16. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.31 million shares which gives us an average trading volume of 10.47 million if we extend that period to 3-months.

Ernexa Therapeutics Inc (NASDAQ:ERNA) trade information

Upright in the green during last session for gaining 4.48%, in the last five days ERNA remained trading in the green while hitting it’s week-highest on Monday, 03/31/25 when the stock touched $0.19 price level, adding 3.99% to its value on the day. Ernexa Therapeutics Inc’s shares saw a change of -35.68% in year-to-date performance and have moved 8.43% in past 5-day. Ernexa Therapeutics Inc (NASDAQ:ERNA) showed a performance of -35.79% in past 30-days. Number of shares sold short was 0.37 million shares which calculate 1.23 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 35.26% during past 5 years.

Ernexa Therapeutics Inc (NASDAQ:ERNA)’s Major holders

Insiders are in possession of 74.94% of company’s total shares while institution are holding 1.90 percent of that, with stock having share float percentage of 7.60%. Investors also watch the number of corporate investors in a company very closely, which is 1.90% institutions for Ernexa Therapeutics Inc that are currently holding shares of the company.

On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund are the top two Mutual Funds which own company’s shares. As of Feb 28, 2025 , the former fund manager was holding 209.56 shares of worth $39627.0 or 0.41% of the total outstanding shares. The later fund manager was in possession of 41.02 shares on Feb 28, 2025 , making its stake of worth around $7756.0 in the company or a holder of 0.08% of company’s stock.